Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.

Abstract excerpt

BACKGROUND & AIMS: Adefovir (ADV) resistance mutations induce low-level cross-resistance to tenofovir in vitro. Our aim was to compare viral kinetics, nucleos(t)ide analog resistance mutations, and quasispecies (QS) evolution during therapy with tenofovir disoproxil fumarate (TDF) or emtricitabine + TDF (FTC/TDF) in selected patients with incomplete ADV responses. METHODS: Patients with chronic hepatitis B and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Deoxycytidine
• Share to Double-Blind Method